Sector Update: Healthcare

By Staff,

Shutterstock photo

Healthcare shares were flat to lower in pre-market trade Thursday.

In healthcare stocks news, Sarepta Therapeutics ( SRPT ) was lower by 1% in pre-market trade after reporting Q4 results that were weaker-than-expected.

The drug developer said its non-GAAP net loss widened to $0.77 per share from a loss of $0.34 the year earlier compared to the $0.71 average loss expected by analysts polled by Capital IQ. Sales fell to $2.6 million from $7.23 million, missing the $4.2 million estimate.

And, NxStage Medical ( NXTM ) reported Q4 earnings that were slightly ahead of analysts' expectations and predicted net losses in Q1 and the full year that were wider than the consensus estimate.

The maker of dialysis products said its net loss in the quarter was $0.08 per share, down from a $0.04 loss the year earlier and compared to the loss of $0.09 average estimate from analysts polled by Capital IQ. Sales rose 7% to $69.4 million, exceeding the $67.8 million consensus.

Finally, Pacira Pharmaceuticals, Inc. ( PCRX ) was up 5% after it said its Phase 3 clinical trial assessing the safety and efficacy of EXPAREL in femoral nerve block for total knee arthroplasty met its primary efficacy endpoint.

This pivotal Phase 3 trial evaluated 183 patients who were randomized to receive either 266 mg of EXPAREL or placebo, with all patients offered rescue narcotics as needed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: SRPT , NXTM , PCRX

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by